Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model

Antiangiogenic therapy in oncology: current status and future directions

(2016) Gordon C Jayson et al.   LANCET

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages

(2016) Teresa E. Peterson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Assessment of Lactotroph Axis Functionality in Mice: Longitudinal Monitoring of PRL Secretion by Ultrasensitive-ELISA

(2015) Anne Guillou et al.   ENDOCRINOLOGY

Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia

(2015) Chandrani Sarkar et al.   INTERNATIONAL JOURNAL OF CANCER

Dopamine: an old target in a new therapy

(2015) Sushanta K. Banerjee   Journal of Cell Communication and Signaling

Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma

(2015) Myrthala Moreno-Smith et al.   NEOPLASIA

Novel insights into G protein and G protein-coupled receptor signaling in cancer

(2014) Morgan O’Hayre et al.   CURRENT OPINION IN CELL BIOLOGY

Dopamine and serotonin regulate tumor behavior by affecting angiogenesis

(2014) Marloes A.M. Peters et al.   DRUG RESISTANCE UPDATES

Sustained Alterations of Hypothalamic Tanycytes During Posttraumatic Hypopituitarism in Male Mice

(2014) Guillaume Osterstock et al.   ENDOCRINOLOGY

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

(2014) Luke H. Hoeppner et al.   Molecular Oncology

Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models

(2014) Carolina Cristina et al.   International Journal of Endocrinology

Heterogeneity of tumor endothelial cells

(2013) Kyoko Hida et al.   CANCER SCIENCE

Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease

(2013) C. Dessapt-Baradez et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endothelial Cell Heterogeneity

(2013) W. C. Aird   Cold Spring Harbor Perspectives in Medicine

Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines

(2012) Chandrani Sarkar et al.   Journal of Neuroimmune Pharmacology

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

(2011) Peter Carmeliet et al.   NATURE REVIEWS DRUG DISCOVERY

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

(2011) Shom Goel et al.   PHYSIOLOGICAL REVIEWS

Anti-VEGF therapy in pituitary carcinoma

(2011) Leon D. Ortiz et al.   Pituitary

Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells

(2011) D. Chakroborty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

(2011) Pipsa Saharinen et al.   TRENDS IN MOLECULAR MEDICINE

Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth

(2010) H. Hashizume et al.   CANCER RESEARCH

G protein-coupled receptors: novel targets for drug discovery in cancer

(2010) Rosamaria Lappano et al.   NATURE REVIEWS DRUG DISCOVERY

Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function

(2010) C. Lafont et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of adherens junction protein expression and localization in pituitary cell networks

(2009) Norbert Chauvet et al.   JOURNAL OF ENDOCRINOLOGY

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

(2009) Hellmut G. Augustin et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1

(2008) N. Korsisaari et al.   CLINICAL CANCER RESEARCH

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

(2008) D. D. Hu-Lowe et al.   CLINICAL CANCER RESEARCH

Prolactin: A Pleiotropic Neuroendocrine Hormone

(2008) D. R. Grattan et al.   JOURNAL OF NEUROENDOCRINOLOGY